NeoGenomics Lab Operations | Hurricane Ian
Important Announcement
NeoGenomics Lab Operations | Hurricane Ian
Orphan CDx assays
Drug development is rapidly outpacing our ability to bring companion diagnostics to market.
MultiOmyx 101: An Introduction to Multiplexing Technology
Cancer claims more than half a million lives each year in the United States alone.
Written By:

Anna Juncker-Jensen
Comprehensive Genomic Profiling (CGP) expands precision medicine’s utility
With the first TKI therapy Imatinib (Gleevec) targeting the fusion BCR-ABL1, approved by FDA in 2001, we have witnessed the birth of modern targeted therapy and personalized medicine.
Written By:

Qinqin Zha
NeoGenomics will be exhibiting at the 2022 ASCO Annual Meeting from June 4 – 6
NeoGenomics will be exhibiting at the 2022 ASCO Annual Meeting from June 4 – 6, 2022.
Diagnostic Symposium
Join NeoGenomics for our upcoming Diagnostic Symposium on Tuesday, May 10, 9 to 10 a.m. PT.
Travelogue 2
On Saturday, March the 12th, after 28 days in China, I was finally allowed to travel to Suzhou.
Written By:

Charlotte Serra